<DOC>
	<DOCNO>NCT02122484</DOCNO>
	<brief_summary>There evidence inflammatory process may play key role surgical myocardial reperfusion . The hypothesis study colchicine , anti-inflammatory agent , may lead reduction periprocedural infarct size , administer elective coronary artery bypass graft surgery .</brief_summary>
	<brief_title>Colchicine Coronary Artery Bypass Graft ( CABG )</brief_title>
	<detailed_description />
	<mesh_term>Colchicine</mesh_term>
	<criteria>The study enroll patient 18 year old old eligible undergo CABG surgery . Excluded patient : age &gt; 80 year old schedule concomitant valve surgery schedule coronary surgery without cardiopulmonary bypass peripheral vascular disease aï¬€ecting upper limb acute coronary syndrome within previous 4 week inotropic mechanical circulatory support induction anaesthesia disorder could potentially increase preoperative cTnI concentration ( eg , percutaneous coronary intervention within previous 6 week ) active inflammatory disease , infectious disease know malignancy treatment corticosteroid , antiinflammatory agent disease modify agent know hypersensitivityallergy colchicine chronic treatment colchicine severe renal failure ( eGFR &lt; 35 ml/min/1.73 m2 ) hepatic failure ( Child Pugh class B C )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>reperfusion damage</keyword>
</DOC>